Charles River Laboratories International (CRL) Earnings

Price: $115.08
Market Cap: $5.65B
Revenue (TTM): $4.05B
Net Income: $22.20M
P/E Ratio: 480.44
EPS (TTM): $0.24

Earnings Dates

Charles River Laboratories International (CRL) reports its earnings quarterly. Here are the key details:

Next Earnings Date
  • Date: May 07, 2025
  • Time of Day: Before Market Open
  • Estimated EPS: $2.06
Last Earnings Report
  • Date: February 19, 2025
  • EPS: $2.66
  • EPS Estimate: $2.5

Charles River Laboratories International's next earnings report is scheduled for May 07, 2025.

In its last earnings report on February 19, 2025, Charles River Laboratories International reported earnings per share (EPS) of $2.66, compared to an estimated EPS of $2.50. The company reported revenue of $1.00B, compared to an estimated revenue of $948.22M.

Earnings Call Transcripts

Transcript Quarter Year Date Estimated EPS Actual EPS
Read Transcript Q4 2024 2025-02-19 $2.50 $2.66
Read Transcript Q3 2024 2024-11-06 $2.42 $2.59
Read Transcript Q2 2024 2024-08-07 $2.39 $2.80
Read Transcript Q1 2024 2024-05-09 $2.06 $2.27
Read Transcript Q4 2023 2024-02-14 $2.39 $2.46
Read Transcript Q3 2023 2023-11-08 $2.35 $2.72
Read Transcript Q2 2023 2023-08-09 $2.63 $2.69
Read Transcript Q1 2023 2023-05-11 $2.59 $2.78
Read Transcript Q4 2022 2023-02-22 $2.75 $2.98
Read Transcript Q3 2022 2022-11-02 $2.51 $2.63
Read Transcript Q2 2022 2022-08-03 N/A N/A
Read Transcript Q1 2022 2022-05-04 N/A N/A
Read Transcript Q4 2021 2022-02-16 N/A N/A
Read Transcript Q3 2021 2021-11-03 N/A N/A
Read Transcript Q2 2021 2021-08-04 N/A N/A
Read Transcript Q1 2021 2021-05-04 N/A N/A
Read Transcript Q4 2020 2021-02-17 N/A N/A
Read Transcript Q3 2020 2020-10-31 N/A N/A
Read Transcript Q2 2020 2020-08-05 N/A N/A
Read Transcript Q1 2020 2020-05-10 N/A N/A
Read Transcript Q4 2019 2020-02-11 N/A N/A
Read Transcript Q3 2019 2019-11-07 N/A N/A
Read Transcript Q2 2019 2019-07-31 N/A N/A
Read Transcript Q1 2019 2019-05-07 N/A N/A
Read Transcript Q4 2018 2019-02-13 N/A N/A
Read Transcript Q3 2018 2018-11-07 N/A N/A
Read Transcript Q2 2018 2018-08-08 N/A N/A
Read Transcript Q1 2018 2018-05-10 N/A N/A
Read Transcript Q4 2017 2018-02-13 N/A N/A
Read Transcript Q3 2017 2017-11-09 N/A N/A
Read Transcript Q2 2017 2017-08-09 N/A N/A
Read Transcript Q1 2017 2017-05-10 N/A N/A
Read Transcript Q4 2016 2017-02-14 N/A N/A
Read Transcript Q3 2016 2016-11-02 N/A N/A
Read Transcript Q2 2016 2016-08-04 N/A N/A
Read Transcript Q1 2016 2016-05-04 N/A N/A

Earnings History

EPS
Estimated EPS
Historical EPS vs Estimated EPS$3.00$3.00$2.00$2.00$1.00$1.00$0.00$0.00Jul '21Jul '2120222022Jul '22Jul '2220232023Jul '23Jul '2320242024Jul '24Jul '2420252025
Download SVG
Download PNG
Download CSV
Revenue
Estimated Revenue
Historical Revenue vs Estimated Revenue$1.20B$1.20B$900.00M$900.00M$600.00M$600.00M$300.00M$300.00M$0.00$0.00Jul '21Jul '2120222022Jul '22Jul '2220232023Jul '23Jul '2320242024Jul '24Jul '2420252025
Download SVG
Download PNG
Download CSV
Date EPS EPS Estimate Revenue Revenue Estimate
February 19, 2025 $2.66 $2.50 $1.00B $948.22M
November 06, 2024 $2.59 $2.42 $1.01B $975.99M
August 07, 2024 $2.80 $2.39 $1.03B $1.02B
May 09, 2024 $2.27 $2.06 $1.01B $992.31M
February 14, 2024 $2.46 $2.39 $1.01B $991.25M
November 08, 2023 $2.72 $2.35 $1.03B $1.00B
August 09, 2023 $2.69 $2.63 $1.06B $1.05B
May 11, 2023 $2.78 $2.59 $1.03B $986.35M
February 22, 2023 $2.98 $2.75 $1.10B $1.04B
November 02, 2022 $2.63 $2.51 $989.16M $970.43M
August 03, 2022 $2.77 $2.73 $973.13M $995.18M
May 04, 2022 $2.75 $2.71 $913.93M $910.10M
February 16, 2022 $2.49 $2.43 $905.05M $888.27M
November 03, 2021 $2.70 $2.57 $895.94M $850.62M
August 04, 2021 $2.61 $2.39 $914.61M $880.44M
May 04, 2021 $2.53 $2.19 $824.57M $798.53M
February 17, 2021 $2.39 $2.11 $790.99M $756.60M

Annual Earnings

Annual Revenue

$4.05B

Fiscal Year 2024
Annual Net Income

$22.20M

Fiscal Year 2024
Annual EPS

$0.67

Fiscal Year 2024
Revenue
NetIncome
Annual Revenue and Net Income$5.00B$5.00B$4.00B$4.00B$3.00B$3.00B$2.00B$2.00B$1.00B$1.00B$0.00$0.00Annual Revenue and Net Income20162016201720172018201820192019202020202021202120222022202320232024202420252025
Download SVG
Download PNG
Download CSV
Annual EPS$10.00$10.00$8.00$8.00$6.00$6.00$4.00$4.00$2.00$2.00$0.00$0.00Annual EPS20162016201720172018201820192019202020202021202120222022202320232024202420252025
Download SVG
Download PNG
Download CSV

Quarterly Earnings

Revenue

$1.00B

Quarter Ending December 28, 2024
Net Income

$-213.75M

Quarter Ending December 28, 2024
EPS

$-4.18

Quarter Ending December 28, 2024
Revenue
NetIncome
Quarterly Revenue and Net Income$1.20B$1.20B$900.00M$900.00M$600.00M$600.00M$300.00M$300.00M$0.00$0.00-$300.00M-$300.00MJul '20Jul '2020212021Jul '21Jul '2120222022Jul '22Jul '2220232023Jul '23Jul '2320242024Jul '24Jul '2420252025
Download SVG
Download PNG
Download CSV
Quarterly EPS$4.00$4.00$2.00$2.00$0.00$0.00-$-2.00-$-2.00-$-4.00-$-4.00-$-6.00-$-6.00Jul '20Jul '2020212021Jul '21Jul '2120222022Jul '22Jul '2220232023Jul '23Jul '2320242024Jul '24Jul '2420252025
Download SVG
Download PNG
Download CSV

Earnings Metrics

Earnings Yield

0.23%

Year Ending December 28, 2024
P/E Ratio

429.84

Year Ending December 28, 2024
Revenue Per Share

$79.00

Year Ending December 28, 2024
Earnings Yield (TTM)

0.21%

Trailing Twelve Months
P/E Ratio (TTM)

480.44

Trailing Twelve Months
Revenue Per Share (TTM)

$79.20

Trailing Twelve Months
Earnings Yield4.39%4.39%3.51%3.51%2.63%2.63%1.76%1.76%0.88%0.88%0.00%0.00%20162016201720172018201820192019202020202021202120222022202320232024202420252025
Download SVG
Download PNG
Download CSV
Price-to-Earnings (P/E) Ratio500.00500.00400.00400.00300.00300.00200.00200.00100.00100.000.000.0020162016201720172018201820192019202020202021202120222022202320232024202420252025
Download SVG
Download PNG
Download CSV

Frequently Asked Questions

Charles River Laboratories International's next earnings date is scheduled for May 07, 2025. The earnings call is expected to take place before market open.

In its last earnings report on February 19, 2025, Charles River Laboratories International reported earnings per share (EPS) of $2.66, compared to an estimated EPS of $2.50. The company reported revenue of $1.00B, compared to an estimated revenue of $948.22M.

Charles River Laboratories International's current Price-to-Earnings (P/E) ratio is 429.84. The trailing twelve months (TTM) P/E ratio is 480.44. The P/E ratio is a valuation metric that compares a company's current share price to its earnings per share (EPS). A higher P/E ratio suggests that investors are expecting higher earnings growth in the future compared to companies with a lower P/E ratio.

For the fiscal year ending December 28, 2024, Charles River Laboratories International reported total revenue of $4.05B and net income of $22.20M. This represents a net profit margin of 0.0054822371.

Charles River Laboratories International's earnings yield is 0.23%. The earnings yield is the inverse of the P/E ratio and represents the percentage of each dollar invested in the stock that was earned by the company.

Charles River Laboratories International's return on equity (ROE) is 0.64%. ROE is a measure of financial performance calculated by dividing net income by shareholders' equity. It measures how effectively management is using a company's assets to create profits.

Charles River Laboratories International's gross profit margin is 32.88%. This indicates that for every dollar of revenue, the company retains $0.33 as gross profit after accounting for the cost of goods sold.

Sections